A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma. [electronic resource]
Producer: 20200206Description: 702-710 p. digitalISSN:- 1573-0646
- Anemia -- chemically induced
- Antineoplastic Agents -- administration & dosage
- Chemoradiotherapy -- adverse effects
- Cisplatin -- administration & dosage
- Drug Eruptions
- Female
- Head and Neck Neoplasms -- therapy
- Humans
- Leukopenia -- chemically induced
- Male
- Maximum Tolerated Dose
- Middle Aged
- Mucositis -- chemically induced
- Squamous Cell Carcinoma of Head and Neck -- therapy
- Survival Analysis
- Treatment Outcome
- Vorinostat -- administration & dosage
- Weight Loss
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.